CrossCountry Consulting Appoints Finance Industry Veteran to Growing Board of Advisors
Jim Logothetis to bring extensive advisory and leadership experience MCLEAN, Va.–(BUSINESS WIRE)–CrossCountry Consulting, a leading…
Month: January 2023
Genesis Energy, L.P. Announces Public Offering of Senior Notes
HOUSTON–(BUSINESS WIRE)–Genesis Energy, L.P. (NYSE: GEL) today announced the commencement of a registered, underwritten public…
Payoneer Announces CFO Transition and Provides Update on 2022 Financial Results
Bea Ordonez to be Successor for Michael Levine NEW YORK–(BUSINESS WIRE)–Payoneer Global Inc. (“Payoneer” or…
Wolters Kluwer’s iLien Motor Vehicle solution wins 2023 BIG Innovation Award
Recent functionality upgrades significantly enhance the user experience MINNEAPOLIS–(BUSINESS WIRE)–#wolterskluwer—Wolters Kluwer Compliance Solutions’ iLien for…
CyrusOne Buys Land for Future Hyperscale Data Center in Northern Virginia
DALLAS–(BUSINESS WIRE)–CyrusOne, a leading global data center developer and operator, announces the purchase of a…
VisualDx Awarded Grant to Advance Global Health and Diagnostic Accuracy in Underserved Regions
The grant from the Bill & Melinda Gates Foundation will support the deployment of decision…
Independent Survey of More Than 1,000 CXO Respondents Across UK, Ireland, Nordics and the GCC Show Continued Plan for Digital Transformation Investments in 2023
CXOs balance need for new investments in digital technologies to drive innovation and interoperability while…
WatchGuard names Simon Yeo Senior Vice President of Operations
Industry veteran and former Barracuda executive to lead company’s IT systems and infrastructure, security, and…
Castellum, Inc. Announces Signing of Non-Binding LOI for East Coast Government Contractor
Castellum, Inc. Announces Signing of Non-Binding LOI for East Coast Government Contractor Castellum, Inc. (NYSE-American:…
Castellum, Inc. Announces Signing of Non-Binding LOI for East Coast Government Contractor
Castellum, Inc. Announces Signing of Non-Binding LOI for East Coast Government Contractor Castellum, Inc. (NYSE-American:…
PharmaTher Holdings Submits for FDA Orphan Drug Designation for Ketamine to Treat Rett Syndrome
TORONTO, Jan. 18, 2023 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB:…
PharmaTher Holdings Submits for FDA Orphan Drug Designation for Ketamine to Treat Rett Syndrome
TORONTO, Jan. 18, 2023 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB:…
ORYZON Announces First Patient In in NET, a Collaborative Phase II Basket Study With Iadademstat in R/R Patients With Neuroendocrine Carcinomas
Collaborative study with Fox Chase Cancer Center Trial will assess the safety and efficacy of…
ORYZON Announces First Patient In in NET, a Collaborative Phase II Basket Study With Iadademstat in R/R Patients With Neuroendocrine Carcinomas
Collaborative study with Fox Chase Cancer Center Trial will assess the safety and efficacy of…
Novan to Present at the Virtual Investor 2023 Companies to Watch Event
Live video webcast on Thursday, January 19th at 12:00 PM ET DURHAM, N.C., Jan. 18,…
Novan to Present at the Virtual Investor 2023 Companies to Watch Event
Live video webcast on Thursday, January 19th at 12:00 PM ET DURHAM, N.C., Jan. 18,…
Hinge Bio Expands Senior Management Team to Drive GEM-DIMER™ Programs to Clinical Development
Barry Selick, Ph.D., successful biopharmaceutical scientist, senior executive and entrepreneur, appointed Chief Executive Officer Carin…
Hinge Bio Expands Senior Management Team to Drive GEM-DIMER™ Programs to Clinical Development
Barry Selick, Ph.D., successful biopharmaceutical scientist, senior executive and entrepreneur, appointed Chief Executive Officer Carin…
European Commission Grants Orphan Drug Designation for aTyr Pharma’s Efzofitimod for Treatment of Sarcoidosis
Global pivotal Phase 3 EFZO-FIT™ study in pulmonary sarcoidosis launched in Europe SAN DIEGO, Jan….
European Commission Grants Orphan Drug Designation for aTyr Pharma’s Efzofitimod for Treatment of Sarcoidosis
Global pivotal Phase 3 EFZO-FIT™ study in pulmonary sarcoidosis launched in Europe SAN DIEGO, Jan….